Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neharika Jain

Cencora Stock: Analyst Estimates & Ratings

Valued at a market cap of $56 billion, Cencora, Inc. (COR) sources and distributes pharmaceutical products for people and animals. The Conshohocken, Pennsylvania-based company provides essential support, encompassing clinical trial logistics and consulting to packaging, data analytics, and patient adherence programs. 

This healthcare company has outpaced the broader market over the past 52 weeks. Shares of COR have surged 21.6% over this time frame, while the broader S&P 500 Index ($SPX) has gained 20.6%. Moreover, on a YTD basis, the stock is up 28.7%, compared to SPX’s 9.6% return. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.